Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

The Journal of Clinical Investigation
M G WingA Compston

Abstract

The administration of the immunosuppressive humanized monoclonal antibody CAMPATH 1-H, which recognizes CD52 on lymphocytes and monocytes, is associated with a first-dose cytokine-release syndrome involving TNFalpha, IFNgamma, and IL-6 clinically. In vitro models have been used to establish the cellular source and mechanism responsible for cytokine release, demonstrating that cytokine release is isotype dependent, with the rat IgG2b and human IgG1 isotype inducing the highest levels of cytokine release, which was inhibited with antibody to CD16, the low affinity Fc-receptor for IgG (FcgammaR). Cross-linking antibody opsonized CD4 T lymphocytes failed to stimulate TNFalpha release, which together with the observation that TNFalpha release by purified natural killer (NK) cells stimulated by fixed autologous CAMPATH 1-H-opsonized targets was inhibited with anti-CD16, indicates that cytokine release results from ligation of CD16 on the NK cells, rather than Fc-receptor (FcR)-dependent cross-linking of CD52 on the targeted cell. Since the hierarchy of isotypes inducing cytokine release in these cultures matches that seen clinically, we conclude that ligation of CD16 on NK cells is also responsible for cytokine release after injectio...Continue Reading

Associated Clinical Trials

Sep 18, 2003·Wyndham Wilson, M.D., Wyndham Wilson, M.D.

References

May 10, 1979·Journal of Immunological Methods·D C Morrison, B J Curry
Sep 26, 1992·Lancet·J D IsaacsH Waldmann
Mar 1, 1990·Tissue Antigens·G HaleH Waldmann
Jul 26, 1990·The New England Journal of Medicine·P W MathiesonH Waldmann
Jul 1, 1989·Cellular Immunology·M R ShalabyT Espevik
Mar 24, 1988·Nature·L RiechmannG Winter
Dec 1, 1981·Transplantation·A B CosimiP S Russell
Jun 1, 1994·The Journal of Clinical Investigation·K J ParlevlietP T Schellekens
Jul 1, 1993·Immunology Today·J D FraserA Weiss
May 1, 1993·European Journal of Immunology·J GreenwoodH Waldmann

❮ Previous
Next ❯

Citations

Feb 3, 2007·Cancer Immunology, Immunotherapy : CII·Herbert RiechelmannMichael Schmitt
Jan 16, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Hans Jürgen DornbuschChristian Urban
Jan 23, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M SerenoM González-Barón
Nov 28, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Alasdair J Coles
Jul 1, 1997·Nature Biotechnology·R E KontermannG Winter
Aug 26, 2006·Nature Clinical Practice. Neurology·Reinhard Hohlfeld, Hartmut Wekerle
Dec 30, 2006·Nature Reviews. Drug Discovery·Vibeke StrandJohn D Isaacs
Mar 23, 2010·Nature Reviews. Drug Discovery·Trevor T HanselAndrew J T George
Dec 22, 1999·British Journal of Haematology·R GamberaleM Giordano
Jun 26, 2001·Clinical and Experimental Immunology·M PonsfordD C Wraith
Aug 16, 2006·The New England Journal of Medicine·Ganesh SuntharalingamNicki Panoskaltsis
Mar 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Aran F LabrijnPaul W H I Parren
Sep 30, 2004·Cancer Biotherapy & Radiopharmaceuticals·Claire Dearden
Nov 21, 2000·Current Opinion in Oncology·J M Flynn, J C Byrd
Oct 13, 2006·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Lourdes P Sejismundo
Jul 13, 2006·The Neurologist·Bruce Cree
Jul 1, 2008·Therapeutic Advances in Neurological Disorders·Ralf A Linker, Bernd C Kieseier
Aug 6, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·J BienvenuJ P Revillard
Feb 5, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Tadeusz Robak
Dec 6, 2011·Bioanalysis·Christopher M KirtonLee A Coney
Apr 26, 2014·Immunotherapy·Carrie M Hersh, Jeffrey A Cohen
Mar 28, 2009·Journal of Neurology·P S RommerU K Zettl
Oct 30, 2004·Leukemia & Lymphoma·Doru T AlexandrescuPeter H Wiernik
Feb 28, 2007·Leukemia & Lymphoma·Sheng-Tsung ChangShih-Sung Chuang
Sep 16, 2011·Leukemia & Lymphoma·Tri-Hung NguyenSrinivas Shankara
Nov 26, 2010·Expert Review of Neurotherapeutics·Edward J Fox
Oct 26, 2013·Expert Opinion on Pharmacotherapy·Franco LocatelliPietro Merli
May 27, 2014·Expert Opinion on Biological Therapy·Carolyn J Owen, Douglas A Stewart
Apr 13, 2007·Expert Opinion on Drug Metabolism & Toxicology·Elizabeth J GribbleSteven D Hughes
May 6, 2014·Experimental Neurology·Joanne L Jones, Alasdair J Coles
Dec 6, 2011·Seminars in Immunology·Jean KwunStuart J Knechtle
Oct 31, 2015·Annual Review of Pharmacology and Toxicology·J WhritenourX Zhu
Jun 26, 2008·Current Opinion in Immunology·Aran F LabrijnJanine Schuurman
Apr 17, 2007·Toxicology in Vitro : an International Journal Published in Association with BIBRA·N Bhogal, R Combes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.